Transitional cell carcinoma laboratory findings

Revision as of 20:57, 10 September 2012 by Vishnu Vardhan Serla (talk | contribs)
Jump to navigation Jump to search

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma laboratory findings

CDC on Transitional cell carcinoma laboratory findings

Transitional cell carcinoma laboratory findings in the news

Blogs on Transitional cell carcinoma laboratory findings

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tests that may be done include:

  • Abdominal CT scan
  • Bladder biopsy (usually performed during cystoscopy)
  • Cystoscopy (examining the inside of the bladder with a camera)
  • Intravenous pyelogram - IVP
  • Pelvic CT scan
  • Urinalysis
  • Urine cytology

References

Template:WH Template:WS